Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin

Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin

Background: The aim of this study is to evaluate the clinical impact of intravesical Bacillus Calmette-Guérin (BCG)-induced changes in blood/urinary immune markers. Methods: Time-course changes in blood/urinary clinical parameters and mRNA expression of 13 genes in urine sediment taken eigh...

Full description

Bibliographic Details
Main Authors:	Makito Miyake, Shunta Hori, Sayuri Ohnishi, Takuya Owari, Kota Iida, Kenta Ohnishi, Yosuke Morizawa, Daisuke Gotoh, Yoshitaka Itami, Yasushi Nakai, Takeshi Inoue, Satoshi Anai, Kazumasa Torimoto, Katsuya Aoki, Tomomi Fujii, Nobumichi Tanaka, Kiyohide Fujimoto
Format:	Article
Language:	English
Published:	MDPI AG 2019-06-01
Series:	Diseases
Subjects:	Bacillus Calmette-Guérin non-muscle invasive bladder cancer tumor-associated macrophage regulatory T cell myeloid-derived suppressor cell intravesical recurrence
Online Access:	https://www.mdpi.com/2079-9721/7/2/44

Similar Items

Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese Cohort
by: Makito Miyake, et al.
Published: (2017-10-01)

Reiter's syndrome postintravesical Bacillus Calmette–Guérin instillations
by: Keng Lim Ng, et al.
Published: (2017-03-01)

Two-stage posterior decompression and fusion for tuberculous spondylitis after intravesical bacillus Calmette-Guerin instillation
by: Hiroki Ohata, et al.
Published: (2021-01-01)

Penile lesion with inguinal adenopathy after intravesical Bacillus Calmette-Guerin instillation therapy
by: Guven Aslan, et al.
Published: (2013-01-01)

Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome
by: R. Waked, et al.
Published: (2020-05-01)

Disfunción orgánica múltiple como complicación de la instilación intravesical de bacilo de Calmette-Guérin
by: Eduardo Moreira, et al.
Published: (2019-07-01)

A case of infectious thoracic aortic aneurysm after intravesical Bacillus Calmette-Guérin instillation therapy for a superficial bladder cancer
by: Shigeki Koterazawa, et al.
Published: (2021-05-01)

Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
by: Paula Cíntia Machado Sampaio, et al.
Published: (2017-08-01)

Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? A population-based cohort study
by: Che-Wei Hsu, et al.
Published: (2020-07-01)

Comparable effect with minimal morbidity of low-dose Tokyo 172 strain compared with regular dose Connaught strain as an intravesical bacillus Calmette-Guérin prophylaxis in nonmuscle invasive bladder cancer: Results of a randomized prospective comparison
by: Teruo Inamoto, et al.
Published: (2013-01-01)

Assessment of angiogenic factor, vascular endothelial growth factor, serum and urine level changes in superficial bladder tumor immunotherapy by intravesical Bacillus Calmette-Guerin
by: Kerigh Behzad, et al.
Published: (2010-01-01)

Intravesical Bacillus Calmette-Guerin for Treatment of Refractory Interstitial Cystitis
by: Saeed Arasteh, et al.
Published: (2007-02-01)

New-onset guttate psoriasis following intravesical immunotherapy of Bacillus Calmette–Guerin
by: Chih-Tsung Hung, et al.
Published: (2012-09-01)

Reactive Arthritis – A Rare Complication of Intravesical BCG Instillation
by: Marta Freixa, et al.
Published: (2020-02-01)

Loss of E cadherin in bladder cancer and its effects on lymphoepithelial interactions
by: Cresswell, Joanne
Published: (2002)

Bacillary Prostatitis after Intravesical Immunotherapy:A Rare Adverse Effect
by: Ana Joaquim, et al.
Published: (2012-02-01)

Economic impacts of the Bacillus Calmette-Guérin (BCG) therapy shortage and the proposed solutions for patients with non-muscle invasive bladder Cancer in Aseer Province, Saudi Arabia
by: Mishari H M Alshyarba, et al.
Published: (2020-01-01)

Single course of intravesical Bacillus Calmette–Guerin versus single course with maintenance therapy in the management of nonmuscle invasive bladder cancer: A prospective randomized study
by: Mohamed Bakr Mohamed, et al.
Published: (2020-01-01)

Bilateral symmetrical corneal melting following intravesical Bacille Calmette-Guerin therapy for bladder carcinoma
by: Chandana Chakraborty, et al.
Published: (2012-01-01)

Intravesical Bacillus Calmette–Guérin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies
by: Makito Miyake, et al.
Published: (2021-05-01)

Prosthetic hip joint infection by Bacillus Calmette-Guerin therapy following intravesical instillation for bladder cancer identified using whole-genome sequencing: a case report
by: Michael Riste, et al.
Published: (2021-02-01)

Non-maintenance intravesical Bacillus Calmette–Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study
by: Makito Miyake, et al.
Published: (2021-03-01)

Reiter’s syndrome occurred following intravesical BCG immunotherapy: Case presentation
by: Fatih Elbir, et al.
Published: (2015-06-01)

Next-Generation Vaccines Based on Bacille Calmette–Guérin
by: Natalie E. Nieuwenhuizen, et al.
Published: (2018-02-01)

Bacillus Calmette-Guerin lymphadenitis: A 6-year experience in two Saudi hospitals
by: E Bukhari, et al.
Published: (2012-01-01)

Reaction at the Bacillus Calmette–Guérin Inoculation Site in Patients with Kawasaki Disease
by: Chi-Chieh Lai, et al.
Published: (2013-02-01)

Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis
by: Di Huang, et al.
Published: (2019-03-01)

Breast abscess due to Bacillus Calmette-Guérin
by: Aurélien Dinh, et al.
Published: (2017-06-01)

Inadvertent intramuscular administration of high dose bacillus Calmette Guerin vaccine in a pre-term infant
by: Asima Banu, et al.
Published: (2013-01-01)

The efficacy and safety of intravesical gemcitabine vs Bacille Calmette-Guérin for adjuvant treatment of non-muscle invasive bladder cancer: a meta-analysis
by: Ye Z, et al.
Published: (2018-08-01)

Bacillus Calmette–Guérin and Bladder Cancer
by: Azad H.A. Razack
Published: (2007-10-01)

Asymptomatic renal BCG granulomatosis: An unusual complication of intravesical BCG therapy for carcinoma urinary bladder
by: Suresh Bhat, et al.
Published: (2015-01-01)

Gluteal abscess: An unusual complication of Bacille Calmette-Guérin
by: Hakan Buyukoglan, et al.
Published: (2011-01-01)

Linfadenitis por vacuna de bacilo Calmette-Guérin
by: Armando Reyes-Cadena
Published: (2015-03-01)

Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
by: Sobana Muthuvelu, et al.
Published: (2019-07-01)

Adverse reactions due to the bacillus Calmette-Guerin vaccine: Twenty Tunisian cases
by: Khadija Sellami, et al.
Published: (2018-01-01)

Mycobacterium bovis Bacille-Calmette-Guérin Infection Aggravates Atherosclerosis
by: Moises A. Huaman, et al.
Published: (2020-12-01)

Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy
by: Vincenzo Serretta, et al.
Published: (2015-01-01)

An Investigation into Improvement of Stability and Efficacy of Intravesical BCG Formulations Using Freeze-Drying Technique
by: Hamidreza Hozouri, et al.
Published: (2021-01-01)

Bacillus Calmette–Guerin immunotherapy for recurrent multiple warts: An open-label uncontrolled study
by: Avtar Kishan Jaisinghani, et al.
Published: (2019-01-01)